Abstract:
Objective his study aims to evaluate the prognostic significance of human telomerase ribonucleic acid component(hTERC) gene overexpression in the natural prognosis of cervical intraepithelial neoplasia grade 1(CIN1).
Methods A total of 2499 women aged 30 to 49 years were screened in a population-based cervical cancer screening study from the rural sites of Jiangxi Province.Using pathology as the gold standard, 74 CIN1 patients first diagnosed by pathological examination were studied.They were observed by carrying the hybrid capture2(hc2) and hTERC genetic testing to understand the baseline.All observed women accepted voluntary follow-up.In the first follow-up conducted 12 months after the screening, the subjects underwent high risk-human papillomavirus(hr-HPV) HC-2 testing.In the second follow-up carried out 24 months after the screening, the patients underwent hr-HPV HC-2, colposcopy, and pathological examinations.
Results A total of 74 CIN1 cases observed were followed-up for 24 months, with disease progression observed in 7 cases(9.5%), stable disease in 25(33.8%), and regression of disease in 42(56.7%).A significant difference in hTERC amplification was observed between the positive and negative groups(χ2=21.07, P < 0.001).The risk of CIN1 persistence and progression in the positive group was 3.24(1.96-5.37) times higher than that in the negative group.A significant difference was found between hr-HPV persist positive and turn to negative or persist negative group(χ2=7.645, P=0.006).A significant difference was also noted between the hTERC gene and the initial test of hr-HPV in both the positive and negative groups(χ2=4.544, P=0.033).
Conclusion A strong association was observed between the prevalence of hTERC gene overexpression and CIN1 natural prognosis.The follow-up results indicated that hr-HPV need repeated testing.A significant difference was noted between hr-HPV persist positive and turn to negative/ persist negative group(χ2=7.645, P=0.006).hTERC gene overexpression could prognoses CIN1 natural prognosis individually.